Prospective randomised controlled trial of video assisted thorascopic (VATS) cytoreductive pleurectomy compared to talc pleurodesis in patients with suspected or proven malignant mesothelioma - MesoVATS study
- Conditions
- Mesothelioma
- Registration Number
- EUCTR2011-001121-24-GB
- Lead Sponsor
- Papworth Hospital NHS Trust
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- Not specified
1. Confirmed or suspected mesothelioma (any sub-type) 2. Associated pleural effusion present 3. Clinically fit and suitable for VAT cytoreductive pleurectomy 4. Able to give Informed consent
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range
1. Unfit for VAT pleurectomy 2. Absence of a pleural effusion 3. Previous attempted pleurodesis by any approach 4. Previous malignancy (Patients who have had a previous malignancy for which they are no longer receiving treatment are eligible to take part in the study provided that they have a confirmed diagnosis of mesothelioma. Those who have had a previous malignancy and do not have a confirmed diagnosis of mesothelioma will not be eligible to take part as we cannot be certain that the pleural disease/effusion is not related to the original cancer). 5. Age < 18
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method